The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Propensity score matched evaluation of epoetin alfa and darbepoetin alfa utilization in patients with cancer receiving chemotherapy.
R. A. Bailey
Employment or Leadership Position - Centocor Ortho Biotech
O. Tunceli
Consultant or Advisory Role - Centocor Ortho Biotech
J. Singer
Consultant or Advisory Role - Centocor Ortho Biotech
J. J. Stephenson
Consultant or Advisory Role - Centocor Ortho Biotech
M. Senbetta
Employment or Leadership Position - Centocor Ortho Biotech